New York State Teachers Retirement System Sells 635 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• The New York State Teachers Retirement System sold 635 shares of Intuitive Surgical, reducing its holdings by 0.2% to 301,075 shares, valued at $163.6 million.
• Insider selling included significant transactions, with Director Amy L. Ladd selling 336 shares and Gary S. Guthart selling 29,360 shares, representing decreases in their ownership stakes of 23.83% and 59.69%, respectively.
• Analysts have mixed ratings for Intuitive Surgical, with 14 analysts rating it a "Buy" while others like Zacks Research have downgraded it to a "Hold," reflecting varying outlooks on the company’s future performance.

New York State Teachers Retirement System cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 301,075 shares of the medical equipment provider's stock after selling 635 shares during the period. New York State Teachers Retirement System owned 0.08% of Intuitive Surgical worth $163,607,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. Duncker Streett & Co. Inc. raised its position in Intuitive Surgical by 62.6% in the second quarter. Duncker Streett & Co. Inc. now owns 4,496 shares of the medical equipment provider's stock worth $2,443,000 after acquiring an additional 1,731 shares during the period. Chesapeake Wealth Management raised its position in Intuitive Surgical by 9.2% in the second quarter. Chesapeake Wealth Management now owns 2,415 shares of the medical equipment provider's stock worth $1,312,000 after acquiring an additional 204 shares during the period. Sagace Wealth Management LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth $257,000. Mutual Advisors LLC increased its stake in shares of Intuitive Surgical by 5.7% in the second quarter. Mutual Advisors LLC now owns 1,605 shares of the medical equipment provider's stock worth $796,000 after purchasing an additional 86 shares in the last quarter. Finally, Ritholtz Wealth Management increased its stake in shares of Intuitive Surgical by 18.9% in the second quarter. Ritholtz Wealth Management now owns 5,633 shares of the medical equipment provider's stock worth $3,061,000 after purchasing an additional 895 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of Intuitive Surgical stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares of the company's stock, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 in the last three months. Corporate insiders own 0.70% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. BTIG Research reduced their price objective on shares of Intuitive Surgical from $571.00 to $529.00 and set a "buy" rating for the company in a research note on Monday. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, October 4th. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Zacks Research cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Finally, Truist Financial reduced their price objective on shares of Intuitive Surgical from $600.00 to $525.00 and set a "buy" rating for the company in a research note on Wednesday. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $582.14.

Intuitive Surgical Stock Performance

ISRG opened at $435.61 on Thursday. The stock has a market capitalization of $156.16 billion, a price-to-earnings ratio of 60.75, a PEG ratio of 4.58 and a beta of 1.61. The company has a fifty day moving average of $456.15 and a 200 day moving average of $496.60. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the company posted $1.78 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.